DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,536,327 | +1.1% | 10,223 | -2.2% | 1.98% | +4.7% |
| Q2 2023 | $2,507,520 | +94345.2% | 10,448 | +4.4% | 1.89% | -6.8% |
| Q4 2022 | $2,655 | -99.9% | 10,003 | -0.5% | 2.03% | -12.3% |
| Q3 2022 | $2,598,000 | +2.0% | 10,058 | +0.1% | 2.31% | +6.5% |
| Q2 2022 | $2,546,000 | -13.7% | 10,045 | -0.1% | 2.17% | -1.0% |
| Q1 2022 | $2,950,000 | -17.0% | 10,057 | -6.9% | 2.19% | -10.2% |
| Q4 2021 | $3,556,000 | +7.6% | 10,808 | -0.5% | 2.44% | -4.0% |
| Q3 2021 | $3,306,000 | +6.1% | 10,860 | -6.4% | 2.55% | +4.0% |
| Q2 2021 | $3,115,000 | +17.9% | 11,606 | -1.2% | 2.45% | +14.8% |
| Q1 2021 | $2,643,000 | +11.7% | 11,742 | +10.2% | 2.13% | +5.2% |
| Q4 2020 | $2,366,000 | -2.7% | 10,651 | -5.7% | 2.03% | -11.0% |
| Q3 2020 | $2,431,000 | +0.5% | 11,289 | -17.5% | 2.28% | -12.5% |
| Q2 2020 | $2,420,000 | +25.6% | 13,686 | -1.7% | 2.60% | +4.4% |
| Q1 2020 | $1,927,000 | -20.5% | 13,921 | -11.9% | 2.49% | +4.8% |
| Q4 2019 | $2,425,000 | +6.7% | 15,801 | +0.5% | 2.38% | -8.6% |
| Q3 2019 | $2,272,000 | -0.4% | 15,730 | -1.4% | 2.60% | -3.0% |
| Q2 2019 | $2,280,000 | +6.4% | 15,949 | -1.7% | 2.68% | +8.6% |
| Q1 2019 | $2,142,000 | -8.9% | 16,226 | -28.8% | 2.47% | +1.7% |
| Q4 2018 | $2,350,000 | -4.4% | 22,788 | +0.8% | 2.43% | +12.1% |
| Q3 2018 | $2,458,000 | +9.8% | 22,618 | -0.3% | 2.17% | +3.3% |
| Q2 2018 | $2,239,000 | -15.6% | 22,688 | -16.2% | 2.10% | -15.6% |
| Q1 2018 | $2,652,000 | +13.4% | 27,086 | +7.5% | 2.49% | +17.5% |
| Q4 2017 | $2,339,000 | +9.2% | 25,196 | +0.9% | 2.12% | +1.1% |
| Q3 2017 | $2,141,000 | +5.1% | 24,964 | +3.4% | 2.10% | +4.8% |
| Q2 2017 | $2,037,000 | -0.3% | 24,140 | +1.0% | 2.00% | -0.9% |
| Q1 2017 | $2,044,000 | +7.0% | 23,900 | -2.7% | 2.02% | +1.6% |
| Q4 2016 | $1,911,000 | -0.7% | 24,555 | +0.0% | 1.99% | -7.6% |
| Q3 2016 | $1,924,000 | -23.6% | 24,545 | -1.5% | 2.15% | -24.5% |
| Q2 2016 | $2,517,000 | +8.0% | 24,920 | +1.5% | 2.85% | +4.5% |
| Q1 2016 | $2,330,000 | -7.2% | 24,560 | -9.2% | 2.73% | +9.6% |
| Q4 2015 | $2,512,000 | +8.9% | 27,040 | -0.1% | 2.49% | -8.3% |
| Q3 2015 | $2,306,000 | +0.6% | 27,065 | +1.1% | 2.71% | +8.5% |
| Q2 2015 | $2,292,000 | +12.2% | 26,780 | +11.3% | 2.50% | +13.7% |
| Q1 2015 | $2,043,000 | +63.3% | 24,068 | +64.9% | 2.20% | +56.9% |
| Q4 2014 | $1,251,000 | – | 14,595 | – | 1.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |